CAScination delivers to India

Please login or
register
13.08.2018
CAS-One IR

The largest government hospital in India introduces an innovative navigation system for minimally invasive treatments for cancer tumors. The system was developed by the Bern medtech company, CAScination.

CAScination develops, manufactures and commercialises navigation systems and surgical robots to improve outcomes for patients undergoing surgical or interventional procedures. One of their products is CAS-One IR, a navigation system for minimally invasive treatment of cancer tumors in the liver, lung, kidney, pancreas and bones.

The gentle treatment with CAScination technology comes with image fusion capabilities to facilitate broader treatment planning and provide a quality control directly after the ablation, aiming to reduce the amount of local recurrences. Compared to conventional surgery, the post-operative stay in hospital is shortened and recovery is faster.

Delhi´s Safdarjung government Hospital has now deployed CAScination’s CAS-One IR navigation system in the hospital, making it the first clinic in India to use such technology. The system was used in April to treat the first patients. Thanks to the positive results with the technology, the hospital opened a new emergency annex to help meet the growing demand for minimally invasive treatment.

CAScination’s CAS-One IR is now in the newly opened emergency block at Safdarjung Hospital. With the addition of almost 260 beds, 37 intensive care unit (ICU) beds and six operation theatres, the new emergency block makes Safdarjung Hospital one of the largest public facilities in India. .Initially, the hospital has 1,840 beds, ranking Safdarjung Hospital among the largest government hospitals in India.

“We rely on the most advanced technology available on the market to perform minimally invasive procedures at our hospital,” says Shabnam Bhandari Grover, Department of Radiology and Imaging, Safdarjung Hospital.

Grover and her team expect to perform over 200 stereotactic ablation treatments per year in the newly built annex, equipped with the latest technology. “We are very happy to be part of this ambitious project and are convinced that Safdarjung will play a leading role in introducing CAScination’s high-accuracy ablation treatment to the whole of India,” says Matthias Peterhans, CEO CAScination AG.

(Press release/ran)

0Comments

More news about

CAScination AG

Company profiles on startup.ch

CAScination AG

rss